| Market cap | $65.17M |
|---|---|
| Enterprise value | N/A |
| Revenue | $40.195M |
|---|---|
| EBITDA | N/A |
| Income | -$7.80 |
| Revenue Q/Q | -30.92% |
| Revenue Y/Y | -34.19% |
| P/E | 0.00 |
|---|---|
| Forward P/E | N/A |
| EV/Sales | 0.21 |
| EV/EBITDA | N/A |
| EV/EBIT | 26.86 |
| PEG | N/A |
| Price/Sales | 1.62 |
| P/FCF | 17.00 |
| Price/Book | 0.66 |
| Book/Share | 1.81 |
| Cash/Share | 0.86 |
| FCF yield | 5.88% |
| Volume | 174.016k / N/A |
|---|---|
| Relative vol. | N/A |
| EPS | N/A |
|---|---|
| EPS Q/Q | N/A |
| Est. EPS Q/Q | N/A |
| Profit margin | -16.08% |
|---|---|
| Oper. margin | -29.19% |
| Gross margin | 20.89% |
| EBIT margin | -23.59% |
| EBITDA margin | 6.12% |
| Ret. on assets | -4.18% |
|---|---|
| Ret. on equity | -7.54% |
| ROIC | -4.67% |
| ROCE | -5.61% |
| Debt/Equity | 0.81 |
|---|---|
| Net debt/EBITDA | -14.27 |
| Current ratio | 11.01 |
| Quick ratio | 8.18 |
| Volatility | 5.20% |
|---|---|
| Beta | 0.72 |
| RSI | 61.69 |
|---|
| Insider ownership | 54.58% |
|---|---|
| Inst. ownership | 20.78% |
| Shares outst. | 29.937M |
|---|---|
| Shares float | 0.000 0.00% |
| Short % of float | 4.42% |
| Short ratio | 13.55 |
| Dividend | N/A |
|---|---|
| Dividend yield | N/A |
| Payout ratio | N/A |
| Payment date | N/A |
| Ex-dividend date | N/A |
| Earnings date | N/A |
Friday, 1 December 2023
|
|
| Retractable Technologies, Inc. Not Impacted by FDA Safety Communication | |
Friday, 30 June 2023
|
|
| Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders | |
Wednesday, 29 March 2023
|
|
| 12 Cheap Healthcare Stocks to Buy in 2023 | |
Monday, 15 August 2022
|
|
| Retractable Technologies, Inc. Results for the Periods Ended June 30, 2022 | |
Saturday, 2 October 2021
|
|
| Here's What Warren Buffett Looks For With Healthcare Stocks | |
Saturday, 28 August 2021
|
|
| 2 Evergreen Value Stocks You Could Buy and Hold Forever | |
Friday, 23 July 2021
|
|
| 3 Value Stocks That Won't Stop Growing | |
Tuesday, 1 June 2021
|
|
| Retractable Technologies, Inc. Receives Notice of Intent to Extend Government Contract | |
Monday, 17 May 2021
|
|
| Retractable Technologies, Inc. Reports $23.4 Million in Operating Income for First Quarter Of 2021 | |
Friday, 8 January 2021
|
|
| Retractable Technologies, Inc. Declares Dividends to Series I and II Class B Convertible Preferred Stock Shareholders - Yahoo Finance | |
Friday, 4 December 2020
|
|
| Why in the World Is Retractable Technologies Stock Up 566%? | |
Monday, 30 November 2020
|
|
| Is Retractable Technologies A Good Stock To Buy Now? | |
Wednesday, 18 November 2020
|
|
| Retractable Technologies, Inc. Reports Increased Income and Sales for Third Quarter Of 2020 | |
Friday, 30 October 2020
|
|
| How Much Does Retractable Technologies' CEO Make? | |
Thursday, 24 September 2020
|
|
| We Like These Underlying Trends At Retractable Technologies | |
Monday, 17 August 2020
|
|
| Retractable Technologies, Inc. Reports Increased Income and Sales for Second Quarter Of 2020 | |
Wednesday, 8 July 2020
|
|
| Here's Why Retractable Technologies Is Skyrocketing 22% Today | |
| What You Need To Know About Retractable Technologies, Inc.'s Investor Composition | |
| Insider |
Trans.
Transaction
|
Total value |
|---|---|---|
| Thomas J Shaw PRESIDENT AND CEO | Buy 5 Jul 2024 | $10,018 |
| Thomas J Shaw PRESIDENT AND CEO | Buy 21 Jun 2024 | $18,169 |
| Thomas J Shaw PRESIDENT AND CEO | Buy 18 Jun 2024 | $76 |
| Thomas J Shaw PRESIDENT AND CEO | Buy 3 Jun 2024 | $6,267 |
| Thomas J Shaw PRESIDENT AND CEO | Buy 29 May 2024 | $13,282 |
| Thomas J Shaw PRESIDENT AND CEO | Buy 22 May 2024 | $28,822 |
| Thomas J Shaw PRESIDENT AND CEO | Buy 21 May 2024 | $18,000 |
| Thomas J Shaw PRESIDENT AND CEO | Buy 16 May 2024 | $55,863 |
| Thomas J Shaw PRESIDENT AND CEO | Buy 15 May 2024 | $1,355 |
| Thomas J Shaw PRESIDENT AND CEO | Buy 10 May 2024 | $10,202 |
| Thomas J Shaw PRESIDENT AND CEO | Buy 6 May 2024 | $4,622 |
Powered by
Robintrack.
| Insider | Age | Since | Compensation |
|---|---|---|---|
| Thomas J. Shaw (70) Founder, Chairman, Pres, and CEO | 70 | $516,716 | |
| Thomas Shaw (69) Chairman of the Board, President, and Chief Executive Officer | 69 | $505,126 | |
| Michele Larios (53) Vice President, General Counsel, and Secretary | 53 | $352,962 | |
| Michele M. Larios (55) VP, Gen. Counsel, and Sec. | 55 | $351,015 | |
| Kathryn M. Duesman RN (58) Exec. Director of Global Health | 58 | $284,520 | |
| John W. Fort III (52) VP, CFO, Principal Accounting Officer, Treasurer, and Director | 52 | $204,000 | |
| John Fort (51) Vice President, Chief Financial Officer, Treasurer, and Director since 2019 | 51 | 2019 | $200,923 |
| Russell B. Kuhlman (67) VP of Sales Devel. | 67 | $156,711 | |
| Russell Kuhlman (66) Vice President and Sales Development | 66 | $151,696 | |
| Darren Findley (56) Independent Director since 2017 | 56 | 2017 | $6,000 |
| Marco Laterza (72) Independent Director since 2005 | 72 | 2005 | $6,000 |
| Walter Bigby (55) Independent Director since 2012 | 55 | 2012 | $6,000 |
| Amy Mack (52) Independent Director since 2007 | 52 | 2007 | $4,000 |
| Patti S. King (63) Director of National Accounts | 63 | ||
| Lawrence G. Salerno (61) Director of Operations | 61 |
our vision: through innovation, education, and the development of safe and reliable medical devices, we strive to be a catalyst in reducing the worldwide spread of infectious disease. our mission: to build a model corporation for employees, customers, community, and shareholders based on performance, pride, and profit; to set a standard for excellence, effectiveness, and integrity in selling and delivering our products; and to establish mutually beneficial relationships with other companies who share our overall vision.
- Health Care > Health Care Supplies
- Retractable Technologies Inc, 511 Lobo Lane, Little Elm 75068-5295, United States
- 972 294 1010
- Investor relations
Profit margin
Debt to assets
Cash flow
Balance sheet
XSLX
| (in millions USD) | 31 Mar 2024 | 31 Dec 2023 | |||
|---|---|---|---|---|---|
| Current assets | |||||
| Cash | $10.011162 | $12.66755 | |||
| Short term investments | $36.630439 | $34.621213 | |||
| Net receivables | $7.424629 | $10.671721 | |||
| Inventory | $19.488819 | $17.581368 | |||
| Total current assets | $75.714344 | $77.649597 | |||
| Long term investments | |||||
| Property, plant & equipment | $91.81545 | $93.478521 | |||
| Goodwill & intangible assets | |||||
| Total noncurrent assets | $100.260749 | $102.022615 | |||
| Total investments | $36.630439 | $34.621213 | |||
| Total assets | $175.975093 | $179.672212 | |||
| Current liabilities | |||||
| Accounts payable | $2.594312 | $4.779035 | |||
| Deferred revenue | |||||
| Short long term debt | $0.31106 | $0.303991 | |||
| Total current liabilities | $6.873941 | $9.377496 | |||
| Long term debt | $1.152802 | $1.233519 | |||
| Total noncurrent liabilities | $69.44172 | $71.007057 | |||
| Total debt | $1.463862 | $1.53751 | |||
| Total liabilities | $76.315661 | $80.384553 | |||
| Stockholders' equity | |||||
| Retained earnings | $39.157332 | $38.785559 | |||
| Other stockholder equity | |||||
| Total stockholder equity | $99.659432 | $99.287659 | |||
| (in millions USD) | 2023 | 2022 | ||
|---|---|---|---|---|
| Current assets | ||||
| Cash | $12.66755 | $19.721345 | ||
| Short term investments | $34.621213 | $29.657314 | ||
| Net receivables | $10.671721 | $4.835119 | ||
| Inventory | $17.581368 | $20.684168 | ||
| Total current assets | $77.649597 | $88.80971 | ||
| Long term investments | ||||
| Property, plant & equipment | $93.478521 | $100.152768 | ||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $102.022615 | $106.855955 | ||
| Total investments | $34.621213 | $29.657314 | ||
| Total assets | $179.672212 | $195.665665 | ||
| Current liabilities | ||||
| Accounts payable | $4.779035 | $6.404925 | ||
| Deferred revenue | ||||
| Short long term debt | $0.303991 | $0.285954 | ||
| Total current liabilities | $9.377496 | $12.135822 | ||
| Long term debt | $1.233519 | $1.533422 | ||
| Total noncurrent liabilities | $71.007057 | $76.993034 | ||
| Total debt | $1.53751 | $1.819376 | ||
| Total liabilities | $80.384553 | $89.128856 | ||
| Stockholders' equity | ||||
| Retained earnings | $38.785559 | $46.028541 | ||
| Other stockholder equity | ||||
| Total stockholder equity | $99.287659 | $106.536809 | ||
Income statement
| (in millions USD) | 31 Mar 2024 | 31 Dec 2023 | |||
|---|---|---|---|---|---|
| Revenue | |||||
| Total revenue | $7.599363 | $14.289513 | |||
| Cost of revenue | $5.698434 | $12.748818 | |||
| Gross profit | $1.900929 | $1.540695 | |||
| Operating activities | |||||
| Research & development | $0.142262 | $0.161697 | |||
| Selling, general & administrative | $4.744804 | $4.158148 | |||
| Total operating expenses | $4.887066 | $4.319845 | |||
| Operating income | -$2.986137 | -$2.77915 | |||
| Income from continuing operations | |||||
| EBIT | $0.548453 | -$0.008658 | |||
| Income tax expense | $0.085586 | $0.029232 | |||
| Interest expense | $0.033483 | $0.035056 | |||
| Net income | |||||
| Net income | $0.429384 | -$0.072946 | |||
| Income (for common shares) | $0.371773 | -$0.130557 | |||
| (in millions USD) | 2023 | 2022 | ||
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $43.596926 | $94.818938 | ||
| Cost of revenue | $34.489115 | $66.565655 | ||
| Gross profit | $9.107811 | $28.253283 | ||
| Operating activities | ||||
| Research & development | $0.581172 | $0.525727 | ||
| Selling, general & administrative | $20.014848 | $28.580532 | ||
| Total operating expenses | $20.59602 | $29.106259 | ||
| Operating income | -$11.488209 | -$0.852976 | ||
| Income from continuing operations | ||||
| EBIT | -$8.764031 | $5.333078 | ||
| Income tax expense | -$1.905161 | $0.08387 | ||
| Interest expense | $0.152166 | $0.170651 | ||
| Net income | ||||
| Net income | -$7.011036 | $5.078557 | ||
| Income (for common shares) | -$7.242982 | $4.846113 | ||
Cash flows
| (in millions USD) | 31 Mar 2024 | 31 Dec 2023 | |||
|---|---|---|---|---|---|
| Net income | $0.429384 | -$0.072946 | |||
| Operating activities | |||||
| Depreciation | $1.889467 | $1.701024 | |||
| Business acquisitions & disposals | |||||
| Stock-based compensation | |||||
| Total cash flows from operations | -$2.022407 | $1.893843 | |||
| Investing activities | |||||
| Capital expenditures | -$0.226396 | -$0.153696 | |||
| Investments | -$0.276326 | -$0.194062 | |||
| Total cash flows from investing | -$0.502722 | -$0.347758 | |||
| Financing activities | |||||
| Dividends paid | |||||
| Sale and purchase of stock | |||||
| Net borrowings | -$0.073648 | -$0.072077 | |||
| Total cash flows from financing | -$0.131259 | -$0.136357 | |||
| Effect of exchange rate | |||||
| Change in cash and equivalents | -$2.656388 | $1.409728 | |||
| (in millions USD) | 2023 | 2022 | ||
|---|---|---|---|---|
| Net income | -$7.011036 | $5.078557 | ||
| Operating activities | ||||
| Depreciation | $7.527227 | $4.602961 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | $10.125813 | |||
| Total cash flows from operations | $2.766848 | $16.768128 | ||
| Investing activities | ||||
| Capital expenditures | -$0.852979 | -$16.830077 | ||
| Investments | -$9.909304 | -$14.372737 | ||
| Total cash flows from investing | -$10.762283 | -$31.202814 | ||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$7.604377 | |||
| Net borrowings | -$0.281866 | -$0.283933 | ||
| Total cash flows from financing | $0.94164 | $4.993118 | ||
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$7.053795 | -$9.441568 | ||
Recent institutional transactions
| Quarter | Shareholder | Change |
Shares owned
Shares
|
Value (in thousands USD) |
|---|---|---|---|---|
| 2024 Q1 | Bridgeway Capital Management |
+45.41%
|
149,534 | $179,441 |
| 2024 Q1 | Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main |
-38.36%
|
36,000 | $43,200 |
| 2024 Q1 | Tls Advisors |
Opened
|
12,152 | $14 |
| 2024 Q1 | State Of Wisconsin Investment Board |
-31.69%
|
25,000 | $30,000 |
| 2024 Q1 | Simplex Trading |
-94.22%
|
684 | $0 |
| 2024 Q1 | Performa Ltd (us) |
-92.86%
|
750 | $900 |
| 2024 Q1 | State Street Corp |
-13.31%
|
59,796 | $71,755 |
| 2024 Q1 | Lpl |
-8.26%
|
75,501 | $90,601 |
| 2024 Q1 | Jones Financial Companies Lllp |
Opened
|
6,400 | $7,680 |
| 2024 Q1 | Wealthtrust Axiom |
+4.48%
|
116,533 | $139,839 |
Institutional shareholders
| Shareholder | Stake |
Shares owned
Shares
|
Value (in thousands USD) |
|---|---|---|---|
| Vanguard Group Inc | 2.40% | 718,395 | |
| Thb Asset Management | 1.29% | 385,403 | |
| Blackrock | 0.92% | 274,599 | |
| Renaissance Technologies | 0.83% | 248,574 | |
| D. E. Shaw & Co | 0.60% | 181,085 | |
| Millennium Management | 0.53% | 159,886 | |
| Bridgeway Capital Management | 0.50% | 149,534 | |
| Geode Capital Management | 0.46% | 137,173 | |
| Wealthtrust Axiom | 0.39% | 116,533 | |
| Lpl | 0.25% | 75,501 |
Sign up